Dc Healthcare Holdings BhdXKLS:0283 36 EBITDA Margin % is 19.70% as of Mar. 2026, which is 19% below its 10-year median of 24.37. GuruFocus rates XKLS:0283 with a GF Score™ of 36/100 and a GF Value™ of RM0.28 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Dc Healthcare Holdings Bhd ranks better than 75.15% on this metric.
Dc Healthcare Holdings Bhd (XKLS:0283) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dc Healthcare Holdings Bhd EBITDA Margin % Related Terms
Dc Healthcare Holdings Bhd EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0283 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Dc Healthcare Holdings Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dc Healthcare Holdings Bhd EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dc Healthcare Holdings Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dc Healthcare Holdings Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dc Healthcare Holdings Bhd (XKLS:0283) has a EBITDA Margin % of 19.70% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dc Healthcare Holdings Bhd and its competitors. This is 19% below median its historical median of 24.37. According to the industry distribution chart, Dc Healthcare Holdings Bhd ranks #166 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.9%.
Is Dc Healthcare Holdings Bhd's EBITDA Margin % too high?
Dc Healthcare Holdings Bhd's current EBITDA Margin % of 19.70% is 19% below median its 10-year median of 24.37. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Dc Healthcare Holdings Bhd's value of 19.70% is 92.9% above this industry median. Based on the distribution chart, Dc Healthcare Holdings Bhd ranks #166 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dc Healthcare Holdings Bhd has a GF Score™ of 36/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dc Healthcare Holdings Bhd's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dc Healthcare Holdings Bhd ranks #166 out of 668 companies for EBITDA Margin %. This places Dc Healthcare Holdings Bhd in the top 25% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Dc Healthcare Holdings Bhd's value of 19.70% is 92.9% above this benchmark. While the company's 10-year median is 24.37 vs. the industry median of 10.21, Dc Healthcare Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dc Healthcare Holdings Bhd's current EBITDA Margin % of 19.70% is 92.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dc Healthcare Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dc Healthcare Holdings Bhd's current EBITDA Margin % is 19.70%, which is 19% below median its own 10-year median of 24.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dc Healthcare Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd (XKLS:0283) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.28, compared to a current price of RM0.11 — trading 62.5% below its estimated fair value. The current EBITDA Margin % is 19.70%, which is 19% below median its 10-year median of 24.37 and 92.9% above the Healthcare Providers & Services industry median of 10.21. Dc Healthcare Holdings Bhd's overall GF Score™ is 36/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dc Healthcare Holdings Bhd (XKLS:0283), the current EBITDA Margin % is 19.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dc Healthcare Holdings Bhd (XKLS:0283) Overvalued in 2026?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.11 is trading 62.5% below its estimated GF Value™ of RM0.28.
GuruFocus considers Dc Healthcare Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0283:
EBITDA Margin %: 19.70% (19% below median its 10-year median of 24.37)
GF Value™: RM0.28 vs. price of RM0.11 (62.5% below fair value)
Industry Position: 92.9% above the Healthcare Providers & Services median (#166 of 668)
No single metric tells the full story. See the XKLS:0283 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dc Healthcare Holdings Bhd Is an investment holding company. Through its subsidiaries, the company provides Aesthetic Services specializing in Non-Invasive and minimally invasive procedures that includes laser skin rejuvenation, pigmentation and acne treatments, anti-ageing procedures, facial contouring solutions and non-invasive body sculpting. The business activities are categorized into three segments, Aesthetic Services, General Medical Services, and Sale of skincare products. The majority of revenue is derived from the Aesthetic Services segment.
36GF Score
Get the complete analysis for XKLS:0283
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0283 has been successfully added to your 
